Malgorzata Olszewska

Medicine · Health Sciences

17h-index6.9kcitations55works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(20), CAR-T cell therapy research(13), Pluripotent Stem Cells Research(10), Virus-based gene therapy research(10), CRISPR and Genetic Engineering(10)

Publications55 total

Supplementary Figures 1-8 from Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia
2025Open Access
Supplementary Tables 1-6 from Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia
2025Open Access
iPSC Reprogramming Identifies the Role of Cryptic Drivers in Preleukemic Clonal Evolution
Blood·2024Open Access
Molecular Consequences and Targeting of PPM1D Mutations and Overexpression in Myeloproliferative Neoplasm Stem Cells
Blood·2024
Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations
Blood·2024· 24 citedOpen Access
2012 – N/KRAS-MUTANT AML LSCS ORIGINATE FROM COMMITTED MYELOMONOCYTIC PROGENITORS AND DRIVE CLINICAL RESISTANCE TO VENETOCLAX
Experimental Hematology·2024
2002 – MATRICELLULAR PROTEIN DEFICIENCY TRANSFORMS MDS TO MYELOID LEUKEMIA THROUGH INDUCTION OF TGF-Β-MEDIATED EPITHELIAL-TO-MESENCHYMAL TRANSITION
Experimental Hematology·2024
Targeting SRSF2 mutations in leukemia with RKI-1447: A strategy to impair cellular division and nuclear structure
iScience·2024· 5 citedOpen Access
Hematopoietic and eosinophil-specific LNK(SH2B3) deficiency promotes eosinophilia and arterial thrombosis
Blood·2023· 11 citedOpen Access
<i>N/KRAS</i>-Mutant AML LSCs Originate from Committed Myelomonocytic Progenitors and Drive Clinical Resistance to Venetoclax
Blood·2023· 5 cited
BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in <i>Tet2</i> Clonal Hematopoiesis
Circulation·2023· 58 citedOpen Access
Supplementary Figures 1-8 from Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia
2023Open Access
Supplementary Tables 1-6 from Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia
2023· 1 citedOpen Access
Supplementary Figures 1-8 from Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia
2023Open Access
Supplementary Tables 1-6 from Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia
2023Open Access
Data from Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia
2023Open Access
Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis
Nature Cardiovascular Research·2023· 63 citedOpen Access
Supplementary Figures 1-8 from Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia
2023Open Access
Data from Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia
2023Open Access
Supplementary Figures 1-8 from Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Eirini P. Papapetrou(31), Andriana G. Kotini(21), Saul Carcamo(17), Dan Hasson(17), Nataly Cruz‐Rodriguez(16), Elsa Bernard(16), Chan-Jung Chang(15), Tiansu Wang(15), Michael G. Kharas(15), Deniz Demircioğlu(15), Hanzhi Luo(14), Mark P. Chao(13), Ravindra Majeti(13), Isabelle Rivière(12), Michel Sadelain(10), Shirley Bartido(9), Jolanta Stefanski(8), Renier J. Brentjens(7), Clare Taylor(7), Marco L. Davila(6)